“…In 13 of 17 studies with a follow-up of between three and 11 years, the survival rate was compliant with the NICE benchmark. [9][10][11]35,[37][38][39]43,44,46,47,49,54 These 13 studies used either the BHR implant (eight), the Conserve Plus (two), the Durom (one), the Cormet 2000 (one) or both the McMinn and the BHR implants (one). The four studies not compliant with this benchmark, but with follow-up of more than three years, used either the ASR device (two), the BHR (one) or the second-generation McMinn device 11,33,34,40 (Fig.…”